Abstract
Magnetic resonance imaging (MRI) is currently considered the gold standard for assessing hemophilic arthropathy (HA) severity; however, MRI is often costly, time-consuming, and difficult to perform in children. In the present study, we evaluated the joint status of hemophilic patients from Shanxi Province, China, using musculoskeletal ultrasonography (MSKUS) and identified the factors that most strongly correlated with disease severity.
The study included 104 patients with hemophilia, who underwent MSKUS examination. A total of 1248 joints (including the shoulder, elbow, wrist, hip, knee, and ankle joints on both sides) from these patients were evaluated. Effusion, hypertrophy, cartilage modification, and bone erosion were assessed. The chi-square test was used to analyze categorical variables, and multivariate logistic regression was used to analyze the relationship between joint disease and risk factors.
MSKUS allowed clear visualization of synovial lesions, effusion, cartilage modification, and bone surface damage; however, it was unable to identify changes deep within bones. The distribution of damaged joints was as follows: shoulder, 2 (1.0%); elbow, 80 (38.5%); wrist, 4 (1.9%); hip, 4 (1.9%); knee, 126 (60.6%); and ankle, 90 (43.3%). Damage was more common in the knee, elbow, and ankle joints than in the shoulder, wrist, and hip joints (P < .001). Among the 1248 joints, 306 showed lesions, which included effusion in 102 (8.2%) joints, synovium hypertrophy in 176 (14.1%), cartilage modification in 193 (15.5%), and bone damage in 176 (14.1%). Many joints had multiple lesions at the same time. The chi-square test and multivariate logistic analysis showed that age and hemophilia severity were significantly associated with joint disease, while type of hemophilia and treatment categories were not associated with joint disease.
MSKUS is a convenient and cost-effective examination that can play an important role in the diagnosis and long-term monitoring of HA.
Keywords: hemophilia, hemophilic arthropathy, musculoskeletal ultrasonography, ultrasonography
1. Introduction
Hemophilia is a sex-linked recessive genetic disorder, and it can be divided into 2 types (hemophilia A and hemophilia B). Hemophilia is more common in male individuals than in female individuals, and the most common symptom is an increased bleeding tendency.[1] Repeated joint bleeding is a serious complication that can cause hemophilic arthropathy (HA) and joint disability.[2] The pathological changes include effusion (hydrarthrosis or hemarthrosis), synovium hypertrophy and hyperemia, cartilage modification, bone erosion, osteophytes, and bone remodeling. The most commonly affected joints are the knee, elbow, and ankle joints,[3] but the shoulder, wrist, and hip joints can also be involved.[4]
For assessing joint status, an appropriate imaging system is needed to evaluate lesion severity and monitor joint disease progression. Conventional radiography has been used to evaluate HA.[5–7] Although radiography can demonstrate the early changes of bone lesions,[8] it only identifies the synovium, and analysis of other soft tissues is difficult.[7] Magnetic resonance imaging (MRI) is presently considered the gold standard for assessing HA severity. It can identify bleeding, synovium hypertrophy, cartilage damage, and osteochondral abnormalities accurately,[9,10] however, it is costly and time-consuming. Furthermore, young children require sedation for MRI examination. Therefore, its use has been greatly limited. Musculoskeletal ultrasonography (MSKUS) is a useful tool for diagnosing and monitoring musculoskeletal diseases.[11–13] It can identify some early changes, such as effusion (hydrarthrosis or hemathrosis), synovium hypertrophy and hyperemia, cartilage damage, and minor alterations of the bone surface. Additionally, many studies have shown a positive relationship between ultrasonography and MRI results.[14–18]
Shanxi Province is a northern province of China, and it is considered to be underdeveloped. In this region, MRI is too expensive for most patients with HA. Thus, in the present study, we assessed the joint status using MSKUS in patients with HA from Shanxi Province.
2. Methods
2.1. Participant
The study included 104 male patients (mean age, 20.8 ± 15.0 years; range 2–68 years) with mild, moderate, or severe hemophilia between April 2015 and April 2016. Among these patients, 1248 joints were evaluated, including the shoulder, elbow, wrist, hip, knee, and ankle joints on both sides. We excluded patients with rheumatoid arthritis and neuropathic arthropathy.
2.2. Diagnostic criteria of hemophilic arthropathy
MSKUS assessments and determination of lesion locations were based on the guidelines for musculoskeletal ultrasonographic examination,[19] and previously published protocols were used for reference.[20,21] Joint effusion was considered abnormal when effusion was >1 mm (knee joint effusion >2 mm), considering that healthy joints might show a small amount of fluid. Measurements were obtained for the shortest axis in the largest pocket of the joint. Synovial hypertrophy was defined as synovial thickness >1.5 mm on gray-scale sonography. The largest anterior–posterior diameter of a single synovial layer of the most affected bursa of the joint was measured.[14,18] Cartilage modification was defined as hyperechogenicity or an irregular profile showing rough or local erosion of the articular cartilage surface. Bone damage was defined as a cortical “break” when an irregular shape was observed in the longitudinal or coronal plane, osteophytes, or bone remodeling. As there is no clear standard for articular cartilage among joint locations, normal cartilage thicknesses were determined from the results of previous studies[22–25] and were compared with the findings of the contralateral joints (if there was no bleeding history) or the joints of 85 healthy volunteers matched by age and sex (if both joints were damaged).
2.3. Ultrasound setting
MSKUS was performed using the Philips IU22 Ultrasonic Diagnostic Apparatus (Philips, Amsterdam, the Netherlands) with a wideband high-frequency 12–5 MHz linear probe.
2.4. The main investigators
One professionally trained operator performed all examinations, who had 8 years of experience for performing MSKUS. All joints were evaluated by a physician on the day of MSKUS examination. Physical examination was performed according to version 2.1 of the hemophilia joint health score.[26]
2.5. Ethics statement
This study was approved by the local internal review boards and ethics committees. Written informed consent was obtained from all patients in accordance with the Declaration of Helsinki.
2.6. Statistical analysis
Continuous data are presented as mean ± standard deviation, while categorical data are presented as percentages. The chi-square test was used to analyze categorical data. To explore the risk factors of hemophilic arthropathy, we used multivariate logistic regression model. Hemophilic arthropathy was set as the dependent variable. The independent variables included the type of hemophilia, age, severity, and treatment categories. All findings were analyzed using two-tailed tests, with statistical significance assumed at P < .05. Analysis was performed using SPSS 22.0 statistical software (IBM Corp., Armonk, NY).
3. Results
The characteristics of all assessed patients are presented in Table 1. We noted that 21.2% of patients received no treatment, 71.2% received on-demand treatment, and only 7.7% received prophylactic treatment (Table 1). Among the 1248 joints examined, 306 showed deterioration (Table 2 and Fig. 1). These included 102 (8.2%) joints with effusion, 176 (14.1%) with synovium hypertrophy, 193 (15.5%) with cartilage modification, and 176 (14.1%) with bone damage. There were 647 lesions in 306 joints, and many joints had multiple lesions at the same time. The shoulder, wrist, and hip joints mainly showed soft tissue lesions and rarely showed osteochondral lesions. However, the knee, elbow, and ankle joints showed all 4 types of lesions. Among the involved joints, the shoulder, wrist, and hip joints accounted for 0.8% of joints with damage, while the knee, elbow, and ankle joints accounted for 99.2% of joints with damage (chi-square test, P < .001) (Fig. 2). The distribution of damaged joints at each location was as follows: shoulder, 2 (1.0%); elbow, 80 (38.5%); wrist, 4 (1.9%); hip, 4 (1.9%); knee, 126 (60.6%); and ankle, 90 (43.3%).
Table 1.
Characteristics of the assessed patients.

Table 2.
Ultrasonography findings of lesions at each location in patients with hemophilia.

Figure 1.

(A1)–(A3): knee joint, (B1)–(B3): elbow joint, (C1)–(C3): ankle joint, (D1)–(D3): shoulder joint, (E1)–(E3): hip joint, (F1)–(F3): wrist joint. The red arrows (between calipers) indicate effusion or hemorrhage (between calipers). Asterisk (∗) represents hypertrophic synovium, and some parts are accompanied by increased color Doppler flow signals. The purple solid arrow indicates the hyperechoic hemosiderin after hemorrhage absorption. The hypoechoic cartilage band is destroyed, shows thinning, or disappears, and the echo shows an increase and nonuniformity (green arrow). The yellow arrow indicates cartilage disappearance, irregular bone surface, or an osteophyte.
Figure 2.

A total of 1248 joints from 104 hemophilia patients were examined. There were 306 abnormal joints on musculoskeletal ultrasonography (black column). Comparison of the incidences of involvement among the various joints according to the chi-square test (P < .001). There is a significant difference between the knee, elbow, and ankle joints and the shoulder, wrist, and hip joints.
On dividing patients into 4 age groups (<6, 6–17, 18–34, and ≥35 years), we found that synovium hypertrophy, cartilage modification, and bone damage significantly increased with age (trend chi-square test, P < .001), while effusion did not increase with age (P > .05) (Fig. 3).
Figure 3.

Effusion, synovium hypertrophy, cartilage destruction, and bone destruction show increases with age. There are significant differences across ages with regard to synovium hypertrophy, cartilage destruction, and bone destruction (trend chi-square test, P < .001), but not effusion (P > .05).
The chi-square test and multivariate logistic regression analysis (Tables 3 and 4) showed that age and hemophilia severity were significantly associated with joint disease (chi-square test: P = .004 and P = .016, respectively; multivariate logistic analysis: P = .015 and P = .010, respectively), while type of hemophilia and treatment categories were not associated with joint disease (chi-square test: P = .557 and P = .261, respectively; multivariate logistic analysis: P = .325 and P = .609, respectively).
Table 3.
Chi-square test to analyze internal differences for the 4 factors with regard to the incidence of the involved joints identified on musculoskeletal ultrasonography.

Table 4.
Multivariate logistic regression analysis to analyze the risk factors associated with joint disease identified on musculoskeletal ultrasonography.

4. Discussion
In recent years, MSKUS has been more extensively applied.[27–31] The present study comprehensively evaluated 12 specific joints in hemophilic patients, using MSKUS. We found that MSKUS can be used to clearly visualise synovial lesions, effusion, cartilage modification, and bone surface damage, but cannot be used to visualise lesions deep within bones. Episodes of bleeding were less common in the shoulder, wrist, and hip joints than in the knee, elbow, and ankle joints, but bleeding was not rare. Additionally, osteochondral damage was lower in the shoulder, wrist, and hip joints than in the knee, elbow, and ankle joints. Similarly, damage to the knee, elbow, and ankle joints was generally more severe, and the incidence of lesions was the highest in the knee joint, followed by the ankle and elbow joints. These findings differ from the results of a study in a Taiwan province that was based on Pettersson scores, in which the prevalence of ankle arthropathy was the highest.[32]
In China, many patients with hemophilia receive either on-demand treatment or no treatment, and few patients receive prophylactic treatment. In this study, 8 patients had received prophylactic treatment, and 6 of these patients had abnormal joints. Notably, there was no positive impact of treatment on joint damage, and this finding differs from the results of previous studies.[33–35] After a telephonic interview, we noted that the 2 patients with normal joints were young children (aged 2 and 5 years) who had undergone primary preventative treatment. Additionally, we noted that 4 of the 6 patients with abnormal joints (aged 2–10 years) had mild synovial hypertrophy (3 patients had mild knee lesions and 1 had a mild ankle lesion) and that they had undergone primary preventative treatment. The other 2 patients with abnormal joint cartilage and bone (aged 23 and 27 years) had undergone tertiary preventative treatment and had started prophylaxis nearly 3 years prior. We found that prophylaxis was more effective when initiated early and at a sufficient dose.
In our study, joint damage increased significantly with increasing age and hemophilia severity, both of which were related to a high number of accumulative bleeding episodes and bleeding-related joint damage. However, we found that they were not influenced by the type of hemophilia or treatment modality. Muça-Perja et al[36] similarly found that the degree of joint involvement was not influenced by the type of hemophilia. Further research with a large sample size may be needed.
We did not consider cartilage calcification for cartilage modification, as epiphyseal plate ossification increases with age in adolescents. Calcification often accompanies hyperechogenicity and an irregular profile. Occasionally, a thickened synovium and fat pads are difficult to differentiate, and color Doppler flow imaging and power Doppler imaging can help distinguish between a thickened synovium and fat pads. In this study, most patients had received on-demand or occasional treatment, thereby resulting in frequent joint bleeding and related joint damage. Among the tools available for monitoring joint status, MRI is often costly and time-consuming. In the Second Hospital of Shanxi Medical University, MRI examination of a joint costs 895
and takes 15–20 minutes irrespective of whether the joint is normal, while MSKUS examination of a joint costs 90
and takes about 5–8 minutes (the examination takes less time if the joint is normal). On the other hand, radiography is associated with poor soft tissue resolution. The advantages of MSKUS are unique as they are beneficial to both patients and physicians,[37–39] and MSKUS is emerging as an important modality for the diagnosis of treatable musculoskeletal abnormalities that contribute to pain in patients with HA.[40,41] Therefore, MSKUS appears to have a potentially critical role in the development of personalized hemophilia care.[13,40]
The present study has some limitations. First, there was no clear definition of articular cartilage thickness according to joint location or patient age. Additionally, there was no specified definition of abnormal joint effusion in joint capsules at different locations. Second, MSKUS was not compared with MRI owing to sample size issues and the expensive nature of MRI. A further study with a large sample size is required to determine normal articular cartilage thickness and abnormal joint effusion. Moreover, comparisons with MRI are needed to determine the efficacy of MSKUS.
5. Conclusion
MSKUS is an economical and convenient imaging approach. It can provide clear images of soft tissue changes and damage to the osteochondral surface. Moreover, it can play an important role in the diagnosis and long-term monitoring of HA, and it may become the first-choice imaging approach for diagnosis, follow-up, and preoperative and postoperative evaluations.
Author contributions
Conceptualization: Cui-ming Zhang, Yu-lin Guo, Lin-hua Yang.
Data curation: Jun-feng Zhang, Jing Xu, Gang Wang.
Formal analysis: Cui-ming Zhang, Jing Xu, Yu-lin Guo.
Investigation: Cui-ming Zhang, Gang Wang, Lin-hua Yang.
Methodology: Jun-feng Zhang, Yu-lin Guo.
Project administration: Cui-ming Zhang, Lin-hua Yang.
Resources: Cui-ming Zhang, Gang Wang.
Supervision: Lin-hua Yang.
Writing – original draft: Cui-ming Zhang, Lin-hua Yang.
Writing – review & editing: Cui-ming Zhang, Lin-hua Yang.
Footnotes
Abbreviations: HA = hemophilic arthropathy, MRI = magnetic resonance imaging, MSKUS = musculoskeletal ultrasonography.
This study was supported by research grants from the Health Development Planning Commission Foundation of Shanxi Province, China (No. 2014046) and the National Natural Science Foundation of China (No. 81573245).
The authors have no conflicts of interest to disclose.
References
- [1].Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of hemophilia. Haemophilia 2013;19:1e1–47. [DOI] [PubMed] [Google Scholar]
- [2].Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994;236:391–9. [DOI] [PubMed] [Google Scholar]
- [3].Klukowska A, Czyrny Z, Laguna P, et al. Correlation between clinical, radiological and ultrasonographical image of knee joints in children with haemophilia. Haemophilia 2001;7:286–92. [DOI] [PubMed] [Google Scholar]
- [4].Carulli C, Rizzo AR, Innocenti M. Hip arthropathy in haemophilia. J Clin Med 2017;6:44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Foppen W, van der Schaaf IC, Beek FJ, et al. Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlas. Eur Radiol 2016;26:1963–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Poonnoose PM, Hilliard P, Doria AS, et al. Correlating clinical and radiological assessment of joints in haemophilia: results of a cross sectional study. Haemophilia 2016;22:925–33. [DOI] [PubMed] [Google Scholar]
- [7].Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980;149:153–9. [PubMed] [Google Scholar]
- [8].Kilcoyne RF, Nuss R. Radiological evaluation of hemophilic arthropathy. Semin Thromb Hemost 2003;29:43–8. [DOI] [PubMed] [Google Scholar]
- [9].Jelbert A, Vaidya S, Fotiadis N. Imaging and staging of haemophilic arthropathy. Clin Radiol 2009;64:1119–28. [DOI] [PubMed] [Google Scholar]
- [10].Funk MB, Schmidt H, Becker S, et al. Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy. Haemophilia 2002;8:98–103. [DOI] [PubMed] [Google Scholar]
- [11].Razek AA, El-Basyouni SR. Ultrasound of knee osteoarthritis: interobserver agreement and correlation with Western Ontario and McMaster Universities Osteoarthritis. Clin Rheumatol 2016;35:997–1001. [DOI] [PubMed] [Google Scholar]
- [12].Mathew AJ, Danda D, Conaghan PG. MRI and ultrasound in rheumatoid arthritis. Curr Opin Rheumatol 2016;28:323–9. [DOI] [PubMed] [Google Scholar]
- [13].Kidder W, Nguyen S, Larios J. Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy. Hemophilia 2015;21:530–7. [DOI] [PubMed] [Google Scholar]
- [14].Di Minno MN, Iervolino S, Soscia E, et al. Magnetic resonance imaging and ultrasound evaluation of “healthy” joints in young subjects with severe haemophilia A. Haemophilia 2013;19: e167–73. [DOI] [PubMed] [Google Scholar]
- [15].Sierra Aisa C, Lucia Cuesta JF, Rubio Martinez A, et al. Comparison of ultrasound and magnetic resonance imaging for diagnosis and follow-up of joint lesions in patients with haemophilia. Haemophilia 2014;20: e51–7. [DOI] [PubMed] [Google Scholar]
- [16].Acharya SS, Schloss R, Dyke JP, et al. Power Doppler sonography in the diagnosis of hemophilic synovitis—a promising tool. J Thromb Haemost 2008;6:2055–61. [DOI] [PubMed] [Google Scholar]
- [17].Doria AS, Keshava SN, Mohanta A, et al. Diagnostic accuracy of ultrasound for assessment of hemophilic arthropathy: MRI correlation. AJR Am J Roentgenol 2015;204:W336–47. [DOI] [PubMed] [Google Scholar]
- [18].Querol F, Cortina V, Cid AR, et al. Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol). Haemophilia 2008;14suppl 6:36–44. [DOI] [PubMed] [Google Scholar]
- [19].American College of Radiology (ACR), Society for Pediatric Radiology (SPR), Society of Radiologists in Ultrasound (SRU) AIUM practice guideline for the performance of a musculoskeletal ultrasound examination. J Ultrasound Med 2012;31:1473–88. [DOI] [PubMed] [Google Scholar]
- [20].Zukotynski K, Jarrin J, Babyn PS, et al. Sonography for assessment of haemophilic arthropathy in children: a systematic protocol. Haemophilia 2007;13:293–304. [DOI] [PubMed] [Google Scholar]
- [21].Melchiorre D, Linari S, Innocenti M, et al. Ultrasound detects joint damage and bleeding in haemophilic arthropathy: a proposal of a score. Haemophilia 2011;17:112–7. [DOI] [PubMed] [Google Scholar]
- [22].Keshava SN, Gibikote SV, Mohanta A, et al. Ultrasound and magnetic resonance imaging of healthy paediatric ankles and knees: a baseline for comparison with haemophilic joints. Haemophilia 2015;21: e210–22. [DOI] [PubMed] [Google Scholar]
- [23].Graichen H, Jakob J, von Eisenhart-Rothe R, et al. Validation of cartilage volume and thickness measurements in the human shoulder with quantitative magnetic resonance imaging. Osteoarthritis Cartilage 2003;11:475–82. [DOI] [PubMed] [Google Scholar]
- [24].Shigematsu K, Hattori K, Kobata Y, et al. A pilot feasibility study for ultrasound evaluation of living human wrist cartilage: site-specific differences in acoustic properties. J Hand Surg Am 2009;34:34–9. [DOI] [PubMed] [Google Scholar]
- [25].Spannow AH, Stenboeg E, Pfeiffer-Jensen M, et al. Ultrasound measurement of joint cartilage thickness in large and small joints in healthy children: a clinical pilot study assessing observer variability. Pediatr Rheumatol Online J 2007;5:3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [26].International Prophylaxis Study Group, Physical Expert Working Group. Hemophilia Joint Health Score 2.1 Instruction Manual. 2015. Available at: http://ipsg.ca/working-groups/physical-theraphy Accessed February 1, 2015. [Google Scholar]
- [27].Razek AA, Fouda NS, Elmetwaley N, et al. Sonography of the knee joint. J Ultrasound 2009;12:53–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Martinoli C, Valle M, Malattia C, et al. Paediatric musculoskeletal US beyond the hip joint. Pediatr Radiol 2011;41suppl 1: S113–24. [DOI] [PubMed] [Google Scholar]
- [29].Razek AA, Al Mahdy Al Belasy F, Ahmed WM, et al. Assessment of articular disc displacement of temporomandibular joint with ultrasound. J Ultrasound 2015;18:159–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Chang KV, Wu WT, Huang KC, et al. Limb muscle quality and quantity in elderly adults with dynapenia but not sarcopenia: an ultrasound imaging study. Exp Gerontol 2018;108:54–61. [DOI] [PubMed] [Google Scholar]
- [31].Chang KV, Wu WT, Han DS, et al. Static and dynamic shoulder imaging to predict initial effectiveness and recurrence after ultrasound-guided subacromial corticosteroid injections. Arch Phys Med Rehabil 2017;98:1984–94. [DOI] [PubMed] [Google Scholar]
- [32].Chang CY, Li TY, Cheng SN, et al. Prevalence and severity by age and other clinical correlates of haemophilic arthropathy of the elbow, knee and ankle among Taiwanese patients with haemophilia. Haemophilia 2017;23:284–91. [DOI] [PubMed] [Google Scholar]
- [33].Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007;357:535–44. [DOI] [PubMed] [Google Scholar]
- [34].Manco-Johnson MJ, Lundin B, Funk S, et al. Effect of late prophylaxis in hemophilia on joint status: a randomized trial. J Thromb Haemost 2017;15:2115–24. [DOI] [PubMed] [Google Scholar]
- [35].Oldenburg J, Zimmermann R, Katsarou O, et al. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand. Haemophilia 2015;21:171–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [36].Muca-Perja M, Riva S, Grochowska B, et al. Ultrasonography of haemophilic arthropathy. Haemophilia 2012;18:364–8. [DOI] [PubMed] [Google Scholar]
- [37].Khan U, Bogue C, Ungar WJ, et al. Cost-effectiveness analysis of different imaging strategies for diagnosis of haemophilic arthropathy. Haemophilia 2010;16:322–32. [DOI] [PubMed] [Google Scholar]
- [38].Wyseure T, Mosnier LO, von Drygalski A. Advances and challenges in hemophilic arthropathy. Semin Hematol 2016;53:10–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [39].Di Minno MN, Ambrosino P, Quintavalle G, et al. Assessment of hemophilic arthropathy by ultrasound: where do we stand? Semin Thromb Hemost 2016;42:541–9. [DOI] [PubMed] [Google Scholar]
- [40].Ceponis A, Wong-Sefidan I, Glass CS, et al. Rapid musculoskeletal ultrasound for painful episodes in adult haemophilia patients. Haemophilia 2013;19:790–8. [DOI] [PubMed] [Google Scholar]
- [41].Di Minno MND, Pasta G, Airaldi S, et al. Ultrasound for early detection of joint disease in patients with hemophilic arthropathy. J Clin Med 2017;6:77. [DOI] [PMC free article] [PubMed] [Google Scholar]
